Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
0.4700
-0.1200 (-20.34%)
At close: Dec 12, 2025, 4:00 PM EST
0.4664
-0.0036 (-0.77%)
After-hours: Dec 12, 2025, 7:59 PM EST
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $28.23 million as of December 12, 2025. Its market cap has decreased by -30.50% in one year.
Market Cap
28.23M
Enterprise Value
21.28M
1-Year Change
-30.50%
Ranking
Category
Stock Price
$0.47
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $28.23M, a decrease of -57.23%. That is a compound annual growth rate of -29.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 28.23M | 6.19% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
| Jun 30, 2023 | 66.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |